Genes that mediate breast cancer metastasis to lung

Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nature Rev. Cancer 2, 563–572 (2002)

Fidler, I. J. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nature Rev. Cancer 3, 453–458 (2003)

Yokota, J. Tumor progression and metastasis. Carcinogenesis 21, 497–503 (2000)

Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537–549 (2003)

Clark, E. A., Golub, T. R., Lander, E. S. & Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532–535 (2000)

Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell 117, 927–939 (2004)

Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418, 823 (2002)

van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009 (2002)

van 't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002)

Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49–54 (2003)

Solomayer, E. F., Diel, I. J., Meyberg, G. C., Gollan, C. & Bastert, G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res. Treat. 59, 271–278 (2000)

Cailleau, R., Olive, M. & Cruciger, Q. V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14, 911–915 (1978)

Minn, A. J. et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44–55 (2005)

Shelly, M. et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J. Biol. Chem. 273, 10496–10505 (1998)

Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signalling network. Nature Rev. Mol. Cell Biol. 2, 127–137 (2001)

Balkwill, F. Cancer and the chemokine network. Nature Rev. Cancer 4, 540–550 (2004)

Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer 2, 161–174 (2002)

Duffy, M. J., Maguire, T. M., Hill, A., McDermott, E. & O'Higgins, N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2, 252–257 (2000)

Framson, P. E. & Sage, E. H. SPARC and tumour growth: where the seed meets the soil? J. Cell. Biochem. 92, 679–690 (2004)

Wood, N. et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J. Exp. Med. 197, 703–709 (2003)

Amatschek, S. et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumour-specific genes. Cancer Res. 64, 844–856 (2004)

O'Hanlon, D. M. et al. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur. J. Cancer 38, 2252–2257 (2002)

Desprez, P. Y., Sumida, T. & Coppe, J. P. Helix–loop–helix proteins in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 225–239 (2003)

Ruzinova, M. B. & Benezra, R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13, 410–418 (2003)

Arun, B. & Goss, P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin. Oncol. 31, 22–29 (2004)

Beer, D. G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Med. 8, 816–824 (2002)

Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000)

Simon, R. Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br. J. Cancer 89, 1599–1604 (2003)

Hynes, R. O. Metastatic potential: generic predisposition of the primary tumour or rare, metastatic variants-or both? Cell 113, 821–823 (2003)

Heimann, R. & Hellman, S. Clinical progression of breast cancer malignant behaviour: what to expect and when to expect it. J. Clin. Oncol. 18, 591–599 (2000)

Schairer, C., Mink, P. J., Carroll, L. & Devesa, S. S. Probabilities of death from breast cancer and other causes among female breast cancer patients. J. Natl. Cancer Inst. 96, 1311–1321 (2004)

Davidson, B. et al. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumour progression. Clin. Cancer Res. 10, 7335–7346 (2004)

Ponomarev, V. et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740–751 (2004)